Nabil Saleh

1.1k citations
29 papers · 756 indexed · h-index 12

Nabil Saleh

29 papers receiving 733 citations

Peers

Nabil Saleh
Comparison fields: 5 of 105
  • Oncology 255
  • Cancer Research 121
  • Biochemistry 29
  • Organic Chemistry 134
  • Immunology 91
Replace Alex Starr with:
Alex Starr Israel
Yaqin Shi China
Yi‐Ru Chen Taiwan
Alok Ranjan United States
Shengyou Liao China
Shakti Ranjan Satapathy India
Sakshi Sikka Singapore
Xianhe Bai United States
Traci E. Battle United States
Nengming Lin China
Nabil Saleh relative to Alex Starr Israel Alex Starr's profile →
Citations per field
00.5×3.5×
Alex Starr · 1×
Citations per year

Countries citing papers authored by Nabil Saleh

Since Specialization
Citations

This map shows the geographic impact of Nabil Saleh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Saleh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Saleh more than expected).

Fields of papers citing papers by Nabil Saleh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Saleh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Saleh. The network helps show where Nabil Saleh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nabil Saleh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nabil Saleh Line = papers co-authored together Nabil Saleh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20245
2 20235
3 202310
4 202312
5 202161
6 202138
7 202128
8 202111
9 201988
10 2017225
11 201710
12
The Effects of Modulation of MMP-2 and MMP-9 in Angiogenesis and Invasive Potential in Retinoblastoma
20151
13 201217
14 201074
15 200780
16 19963
17 19921
18 19903
19
Synthesis and Biological Evaluation of Some New Thienopyridine and Thienopyrimidine Derivatives
19833
20 197717

About Nabil Saleh

Nabil Saleh is a scholar working on Accounting, Oncology and Biological Psychiatry, having authored 29 papers that have together received 756 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Advanced Breast Cancer Therapies (4 papers), Synthesis and biological activity (4 papers), Islamic Finance and Banking Studies (4 papers), CAR-T cell therapy research (3 papers), Synthesis of heterocyclic compounds (3 papers), Cancer Mechanisms and Therapy (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (255 citations), Cancer Research (121 citations) and Biochemistry (29 citations). Nabil Saleh has collaborated with scholars based in United States, Libya and Egypt. Frequent co-authors include Rabia Alghazeer, Ann Richmond, Sheau‐Chiann Chen, Qiuhua Zhang, Ahmed M. M. El‐Saghier, Rachel C. Brennan, Jena J. Steinle, Vanessa Morales-Tirado, Dianna A. Johnson and Zachary K. Goldsmith. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences and Journal of neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026